Emergence of Fosfomycin Resistance by Plasmid-Mediated Genes in Uropathogenic ESBL-Producing Isolates in Mexico.

Fosfomycin is currently a viable option against urinary tract infections, particularly against extended-spectrum β-lactamases (ESBL)-producing , due to its unique mechanism of action and its low resistance among bacteria. The objective of this study was to investigate two of the three most common mechanisms of resistance against this antibiotic among 350 ESBL-producing strains isolated from the urine of Mexican patients. The prevalence of fosfomycin resistance in our study was 10.